DOI:
10.1055/s-00000071
Seminars in Neurology
LinksClose Window
References
Reardon DA, Kaley T, Dietrich J. , et al.
Phase 2 study to evaluate the clinical efficacy and safety of MEDI4736 (durvalumab [DU]) in patients with glioblastoma (GBM): results for cohort B (DUR monotherapy), bevacizumab naive patients with recurrent GBM.
Paper presented at: 21st Annual Meeting of the Society for Neuro-Oncology2016; Scottsdale, Arizona
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.